nach oben

International Urogynecology Journal

Erschienen in:

04.01.2022 | Review Article

Do vaginal pessaries used to treat pelvic organ prolapse impact on sexual function? A systematic review and meta-analysis

verfasst von: Laura Wharton, Ruth Athey, Swati Jha

Erschienen in: International Urogynecology Journal | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Pelvic organ prolapse (POP) is common and associated with sexual dysfunction. Vaginal pessaries are an effective treatment for POP, but their impact on sexual function is not well established. The aim of this systematic review and meta-analysis was to establish the impact of vaginal pessaries used for POP on female sexual function.

Methods

Systematic review of the literature following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and checklist. A comprehensive search was conducted across Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews, EMBASE, MEDLINE, CINAHL, ClinicalTrials.gov, The WHO International Clinical Trials Registry Platform, ProQuest Dissertations & Theses, Open Grey and Scopus Citation Database. Randomised controlled trials and cohort studies that assessed sexual function in women pre- and post-pessary treatment for POP were included, assessed for risk of bias and their results synthesised.

Results

A total of 1,945 titles and abstracts were screened, 104 full-text articles were assessed for eligibility, 14 studies were included in the narrative analysis and 7 studies were included in the meta-analysis. The results suggest that, in sexually active women, there is no evidence of a deterioration in sexual function and some evidence of an improvement.

Discussion

This review offers reassurance that in sexually active women who successfully use a pessary for treatment of their prolapse, there is no deterioration in sexual function. There is some evidence of an improvement in sexual function, but given the clinical heterogeneity in the studies included, caution should be taken in generalising these findings.

Nur mit Berechtigung zugänglich

Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27:165–94. https://doi.org/10.1007/s00192-015-2932-1.CrossRefPubMed

Swift SE. The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol. 2000;183:277–85. https://doi.org/10.1067/mob.2000.107583.CrossRefPubMed

Nygaard IM, Bradley CM, Brandt DR, Women's Health Initiative. Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol. 2004;104:489–97. https://doi.org/10.1097/01.AOG.0000136100.10818.d8.CrossRefPubMed

Fatton B, de Tayrac R, Letouzey V, Huberlant S. Pelvic organ prolapse and sexual function. Nat Rev Urol. 2020;17:373–90.CrossRefPubMed

Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006;194:1455–61. https://doi.org/10.1016/j.ajog.2006.01.060.CrossRefPubMed

Lowenstein L, Gamble T, Sanses TVD, van Raalte H, Carberry C, Jakus S, et al. Sexual function is related to body image perception in women with pelvic organ prolapse. J Sex Med. 2009;6:2286–91. https://doi.org/10.1111/j.1743-6109.2009.01329.x.CrossRefPubMed

Rogers RG, Pauls RN, Thakar R, Morin M, Kuhn A, Petri E, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction. Neurourol Urodyn. 2018;37:1220–40. https://doi.org/10.1002/nau.23508.CrossRefPubMed

Brown CA, Pradhan A, Pandeva I. Current trends in pessary management of vaginal prolapse: a multidisciplinary survey of UK practice. Int Urogynecol J. 2021;32(4):1015–22.CrossRefPubMed

Rantell A. Vaginal pessaries for pelvic organ prolapse and their impact on sexual function. Sex Med Rev. 2019;7:597–603. https://doi.org/10.1016/j.sxmr.2019.06.002.CrossRefPubMed

10.

Jha S, Gray T. A systematic review and meta-analysis of the impact of native tissue repair for pelvic organ prolapse on sexual function. Int Urogynecol J. 2015;26:321–7. https://doi.org/10.1007/s00192-014-2518-3.CrossRefPubMed

11.

Antosh DD, Kim-Fine S, Meriwether KV, Kanter G, Dieter AA, Mamik MM, et al. Changes in sexual activity and function after pelvic organ prolapse surgery: a systematic review. Obstet Gynecol. 2020;136:922–31. https://doi.org/10.1097/AOG.0000000000004125.CrossRefPubMed

12.

Kearney R, Brown C. Self-management of vaginal pessaries for pelvic organ prolapse. BMJ Qual Improv Rep. 2014;3:u206180.w2533. https://doi.org/10.1136/bmjquality.u206180.w2533.CrossRefPubMedPubMedCentral

13.

Lough K, Hagen S, McClurg D, Pollock A. Shared research priorities for pessary use in women with prolapse: results from a James Lind Alliance priority setting partnership. BMJ Open. 2018;8:e021276. https://doi.org/10.1136/bmjopen-2017-021276.CrossRefPubMedPubMedCentral

14.

Roy Rosenzweig Centre for History and New Media. Zotero. Virginia: Fairfax; 2021.

15.

Microsoft Corporation. Microsoft Excel. 2021.

16.

Meriwether KV, Komesu YM, Craig E, Qualls C, Davis H, Rogers RG. Sexual function and pessary management among women using a pessary for pelvic floor disorders. J Sex Med. 2015;12:2339–49. https://doi.org/10.1111/jsm.13060.CrossRefPubMedPubMedCentral

17.

Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.

18.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.

19.

Constantine ML, Pauls RN, Rogers RR, Rockwood TH. Validation of a single summary score for the prolapse/incontinence sexual questionnaire–IUGA revised (PISQ-IR). Int Urogynecol J. 2017;28:1901–7. https://doi.org/10.1007/s00192-017-3373-9.CrossRefPubMed

20.

Kuhn A, Bapst D, Stadlmayr W, Mueller MD, Vits K. Sexual and organ function in patients with symptomatic prolapse: are pessaries helpful? Fertil Steril. 2009;91:1914–8.CrossRefPubMed

21.

Espitia De La Hoz FJ. Evaluation of quality of life in climacteric women with genital prolapse after the use of pessary. J Sexual Med. 2017;14(12 Supplement):e373–4.

22.

Espitia F. Evaluación de la calidad de vida en mujeres climatéricas con prolapso genital luego del uso del pesario. Rev Colomb Menopaus 2018;24(4)::7–18.

23.

Panman CMCR, Wiegersma M, Kollen BJ, Berger MY, Lisman-Van LY, Dekker JH, et al. Effectiveness and cost-effectiveness of pessary treatment compared with pelvic floor muscle training in older women with pelvic organ prolapse: 2-year follow-up of a randomized controlled trial in primary care. Menopause. 2016;23:1307–18.CrossRefPubMed

24.

Abdool Z, Thakar R, Sultan A, Oliver R. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2011;22:273–8. https://doi.org/10.1007/s00192-010-1340-9.CrossRef

25.

Albuquerque Coelho SC, Marangoni-Junior M, Brito LGO, De Castro EB, Juliato CRT. Quality of life and vaginal symptoms of postmenopausal women using pessary for pelvic organ prolapse: a prospective study. Rev Assoc Med Bras. 2018;64:1103–7. https://doi.org/10.1590/1806-9282.64.12.1103.CrossRef

26.

Anantawat T, Manonai J, Wattanayingcharoenchai R, Sarit-apirak S. Impact of a vaginal pessary on the quality of life in women with pelvic organ prolapse. Asian Biomed. 2016;10:249–52. https://doi.org/10.5372/1905-7415.1003.487.CrossRef

27.

Carlin GL, Morgenbesser R, Kimberger O, Umek W, Bodner K, Bodner-Adler B. Does the choice of pelvic organ prolapse treatment influence subjective pelvic-floor related quality of life? Eur J Obstet Gynecol Reprod Biol. 2021;259:161–6. https://doi.org/10.1016/j.ejogrb.2021.02.018.CrossRefPubMed

28.

Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol. 2006;108:93–9.CrossRefPubMed

29.

Lone F, Thakar R, Sultan AH. One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires. Int Urogynecol J Pelvic Floor Dysfunct. 2015;26:1305–12. https://doi.org/10.1007/s00192-015-2686-9.CrossRef

30.

Lowenstein L, Gamble T, Sanses TVD, van Raalte H, Carberry C, Jakus S, et al. Changes in sexual function after treatment for prolapse are related to the improvement in body image perception. J Sex Med. 2010;7:1023–8. https://doi.org/10.1111/j.1743-6109.2009.01586.x.CrossRefPubMed

31.

Mamik MM, Rogers RG, Qualls CR, Komesu YM. Goal attainment after treatment in patients with symptomatic pelvic organ prolapse. Am J Obstet Gynecol. 2013;209(488):e1–5. https://doi.org/10.1016/j.ajog.2013.06.011.CrossRef

32.

Pezzella M, Iervolino SA, Passaretta A, Torella M, Colacurci N. Sexual function among women using a pessary for pelvic organ prolapse. Neurourol Urodyn. 2017;36:S5–87. https://doi.org/10.1002/nau.23302.CrossRef

33.

Radnia N, Hajhashemi M, Eftekhar T, Deldar M, Mohajeri T, Sohbati S, et al. Patient satisfaction and symptoms improvement in women using a vaginal pessary for the treatment of pelvic organ prolapse. J Med Life. 2019;12:271–5. https://doi.org/10.25122/jml-2019-0042.CrossRefPubMedPubMedCentral

34.

Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.

35.

Brincat C, Kenton K, Pat Fitzgerald M, Brubaker L. Sexual activity predicts continued pessary use. Am J Obstet Gynecol. 2004;191:198–200.CrossRefPubMed

36.

Hagen S, Kearney R, Goodman K, Melone L, Elders A, Manoukian S, et al. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial. Trials. 2020;21:837. https://doi.org/10.1186/s13063-020-04738-9.CrossRefPubMedPubMedCentral

37.

Bradshaw HD, Hiller L, Farkas AG, Radley S, Radley SC. Development and psychometric testing of a symptom index for pelvic organ prolapse. J Obstet Gynaecol. 2006;26:241–52. https://doi.org/10.1080/01443610500537989.CrossRefPubMed

38.

Price N, Jackson SR, Avery K, Brookes ST, Abrams P. Development and psychometric evaluation of the ICIQ vaginal symptoms questionnaire: the ICIQ-VS. BJOG. 2006;113:700–12. https://doi.org/10.1111/j.1471-0528.2006.00938.x.CrossRefPubMed

39.

Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208. https://doi.org/10.1080/009262300278597.CrossRefPubMed

40.

Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:164–8; discussion 168. https://doi.org/10.1007/s00192-003-1063-2.CrossRefPubMed

41.

Rogers RG, Rockwood TH, Constantine ML, Thakar R, Kammerer-Doak DN, Pauls RN, et al. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-revised (PISQ-IR). Int Urogynecol J. 2013;24:1091–103. https://doi.org/10.1007/s00192-012-2020-8.CrossRefPubMed

42.

Baeßler K, Junginger B. Beckenboden-Fragebogen für Frauen. Aktuelle Urol. 2011;42:316–22. https://doi.org/10.1055/s-0031-1271544.CrossRefPubMed

Titel: Do vaginal pessaries used to treat pelvic organ prolapse impact on sexual function? A systematic review and meta-analysis
verfasst von: Laura Wharton
Ruth Athey
Swati Jha
Publikationsdatum: 04.01.2022
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal / Ausgabe 2/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-021-05059-4

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Do vaginal pessaries used to treat pelvic organ prolapse impact on sexual function? A systematic review and meta-analysis

Abstract

Introduction and hypothesis

Methods

Results

Discussion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Healthcare utilization following minimally invasive apical prolapse repair in a large integrated healthcare system

Robot-assisted sacrocolpopexy: not only for vaginal vault suspension? An observational cohort study

Pelvic organ prolapse recurrence after apical prolapse repair: does obesity matter?

Long term outcomes of laparoscopic sacro/colpo-hysteropexy with and without rectopexy for the treatment of prolapse

The polymorphisms of extracellular matrix-remodeling genes are associated with pelvic organ prolapse

Pelvic floor muscle injury during a difficult labor. Can tissue fatigue damage play a role?

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie